Senior insider sale
Vice President, Finance at CYMABAY THERAPEUTICS, INC. — senior position signals high conviction
$3.74M
156.50K shares
MENOLD DANIEL plans to sell 156.50K shares of CYMABAY THERAPEUTICS, INC. valued at approximately $3.74M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Stock Option Exercise
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/15/2024 | Stock Option Exercise Cash | 10K | — |
| Total | 10K | ||
Completed
Units to sell
25K
Market value
$600.0K
Units to sell
25K
Market value
$587.5K
Units to sell
45K
Market value
$1.06M
Units to sell
20K
Market value
$460.8K
Units to sell
10K
Market value
$235.8K
Units to sell
10K
Market value
$219.8K
Units to sell
11.50K
Market value
$252.8K
Planned — Approximate Date
Units to sell
10K
Market value
$321.8K
Units
156.50K
Value
$3.74M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/1/2024 | 25K | $600.0K | — | Completed |
1/30/2024 | 25K | $587.5K | — | Completed |
1/29/2024 | 45K | $1.06M | — | Completed |
1/26/2024 | 20K | $460.8K | — | Completed |
1/16/2024 | 10K | $235.8K | — | Completed |
12/15/2023 | 10K | $219.8K | — | Completed |
12/15/2023 | 11.50K | $252.8K | — | Completed |
| Planned — Approximate Date | ||||
2/15/2024 | 10K | $321.8K | NASDAQ | Planned |
| Total | 156.50K | $3.74M | ||